145 related articles for article (PubMed ID: 6342639)
1. Epoprostenol (prostacyclin, PGI2) binding and activation of adenylate cyclase in platelets of diabetic and control subjects.
Shepherd GL; Lewis PJ; Blair IA; de Mey C; MacDermot J
Br J Clin Pharmacol; 1983 Jan; 15(1):77-81. PubMed ID: 6342639
[TBL] [Abstract][Full Text] [Related]
2. Effects of heparin on prostacyclin binding and platelet adenylate cyclase activity stimulated by iloprost and forskolin.
Jaschonek K; Faul C; Daiss W; Weisenberger H
Prostaglandins Leukot Med; 1986 Oct; 24(2-3):199-206. PubMed ID: 2432618
[TBL] [Abstract][Full Text] [Related]
3. (5Z)-carbacyclin discriminates between prostacyclin-receptors coupled to adenylate cyclase in vascular smooth muscle and platelets.
Corsini A; Folco GC; Fumagalli R; Nicosia S; Noe MA; Oliva D
Br J Pharmacol; 1987 Jan; 90(1):255-61. PubMed ID: 3545351
[TBL] [Abstract][Full Text] [Related]
4. Prostacyclin-lipoprotein interactions. Studies on human platelet aggregation and adenylate cyclase.
Colli S; Maderna P; Tremoli E; Baraldi A; Rovati GE; Gianfranceschi G; Nicosia S
Biochem Pharmacol; 1985 Jul; 34(14):2451-7. PubMed ID: 3893439
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of platelet aggregation by prostacyclin is attenuated after exercise in patients with angina pectoris.
Kishi Y; Ashikaga T; Numano F
Am Heart J; 1992 Feb; 123(2):291-7. PubMed ID: 1736562
[TBL] [Abstract][Full Text] [Related]
6. Heparin does not interfere with prostacyclin and prostaglandin D2 binding to platelets.
Fortini A; Modesti PA; Abbate R; Gensini GF; Neri Serneri GG
Thromb Res; 1985 Nov; 40(3):319-28. PubMed ID: 3001968
[TBL] [Abstract][Full Text] [Related]
7. Effects of TRK-100, a stable prostacyclin analogue, on regulation of cyclic AMP metabolism in platelets.
Nogimori K; Kajikawa N; Nishio S; Yajima M
Prostaglandins; 1989 Feb; 37(2):205-12. PubMed ID: 2543034
[TBL] [Abstract][Full Text] [Related]
8. Functional and ligand binding studies suggest heterogeneity of platelet prostacyclin receptors.
Armstrong RA; Lawrence RA; Jones RL; Wilson NH; Collier A
Br J Pharmacol; 1989 Jul; 97(3):657-68. PubMed ID: 2474350
[TBL] [Abstract][Full Text] [Related]
9. Prostacyclin increases cyclic AMP levels and adenylate cyclase activity in platelets.
Best LC; Martin TJ; Russell RG; Preston FE
Nature; 1977 Jun; 267(5614):850-2. PubMed ID: 197414
[No Abstract] [Full Text] [Related]
10. Interrelationships between PGE1 and PGI2 binding and stimulation of adenylate cyclase.
Garrity MJ; Westcott KR; Eggerman TL; Andersen NH; Storm DR; Robertson RP
Am J Physiol; 1983 Apr; 244(4):E367-72. PubMed ID: 6132556
[TBL] [Abstract][Full Text] [Related]
11. Prostaglandin endoperoxide analogues which are both thromboxane receptor antagonists and prostacyclin mimetics.
Armstrong RA; Jones RL; MacDermot J; Wilson NH
Br J Pharmacol; 1986 Mar; 87(3):543-51. PubMed ID: 3026540
[TBL] [Abstract][Full Text] [Related]
12. Platelets of pseudohypoparathyroid patients: evidence that distinct receptor-cyclase coupling proteins mediate stimulation and inhibition of adenylate cyclase.
Motulsky HJ; Hughes RJ; Brickman AS; Farfel Z; Bourne HR; Insel PA
Proc Natl Acad Sci U S A; 1982 Jul; 79(13):4193-7. PubMed ID: 6287473
[TBL] [Abstract][Full Text] [Related]
13. Refractoriness of platelets to prostaglandins after infusion in rabbits.
Bertelé V; Stemerman M; Schafer A; Adelman B; Smith M; Fuhro R; Salzman E
J Lab Clin Med; 1985 Nov; 106(5):551-61. PubMed ID: 2997353
[TBL] [Abstract][Full Text] [Related]
14. Cytochemical localization of adenylate cyclase in the dense tubule system of human blood platelets stimulated by forskolin, prostacyclin and prostaglandin D2.
Cutler LS; Christian CP; Feinstein MB
Biochim Biophys Acta; 1985 Jun; 845(3):403-10. PubMed ID: 3890960
[TBL] [Abstract][Full Text] [Related]
15. Decreased plasma prostacyclin-regenerating activities in diabetics.
Sensaki S; Okuma M; Uchino H
Prostaglandins Leukot Med; 1985 Nov; 20(2):197-207. PubMed ID: 3906672
[TBL] [Abstract][Full Text] [Related]
16. Abnormality of adenylate cyclase regulation in human platelet membranes in renal insufficiency.
Jacobsson B; Ransnäs L; Nyberg G; Bergh CH; Magnusson Y; Hjalmarson A
Eur J Clin Invest; 1985 Apr; 15(2):75-81. PubMed ID: 2986984
[TBL] [Abstract][Full Text] [Related]
17. Modulation of human platelet adenylate cyclase by prostacyclin (PGX).
Gorman RR; Bunting S; Miller OV
Prostaglandins; 1977 Mar; 13(3):377-88. PubMed ID: 191876
[TBL] [Abstract][Full Text] [Related]
18. Human prostacyclin platelet receptors in diabetes mellitus.
Modesti PA; Fortini A; Gensini GF; Vanni D; Prisco D; Abbate R
Thromb Res; 1991 Sep; 63(5):541-8. PubMed ID: 1755006
[TBL] [Abstract][Full Text] [Related]
19. Purification and properties of prostaglandin E1/prostacyclin receptor of human blood platelets.
Dutta-Roy AK; Sinha AK
J Biol Chem; 1987 Sep; 262(26):12685-91. PubMed ID: 2887571
[TBL] [Abstract][Full Text] [Related]
20. Specific binding of the new stable epoprostenol analogue beraprost sodium to prostacyclin receptors on human and rat platelets.
Kajikawa N; Nogimori K; Murata T; Nishio S; Uchiyama S
Arzneimittelforschung; 1989 Apr; 39(4):495-9. PubMed ID: 2665758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
